Presentations and films
2023
ESMO TAT CONGRESS 2023
2022
Presentation Q32022
Investor's teleconference 1Q 2022
2021
Investor's teleconference
Capital Markets Day - 21.04.2021
Transcript >
Watch full CMD webcast >
Corporate deck >
Watch KOL's session >
Watch Corporate session >
Celon Pharma Announces Positive Falkieri Phase II Results in Treatment-Resistant Bipolar Depression
Shareholders of Celon Pharma S.A. On February 16, 2021, they will decide to authorize the Management Board to increase the share capital within the authorized capital by issuing new shares.